Job Offers

Top 5 - yesterday

Top 5 - last week

Top 5 - last month

US (CA): Grower commences tissue culture protocols

Pharmagreen Biotech has commenced developing tissue culture protocol for each of the top Cannabis Strains sold and grown in California. This cannabis market is estimated to be over $6 Billion annually.  The cannabis strains targeted for protocol development (scientific process for plant reproduction where each strain has its own protocol) are some of the top strains currently being grown in California by cultivators.  California market is very unique with well established, highly experienced breeders for top Cannabis strains.  Their strains are never lacking in potency, flavor, or aesthetics.  

Each strain development can take months to complete. "Commencing the research on the development of the tissue culture protocols will provide a much faster time to full scale production of starter plantlets," the Pharmagreen team explains. 

Controlling the entire supply chain from plantlet (tissue cultured starter plantlets) to sale (state of the art greenhouse grade A flower tops) gives Pharmagreen a high level of control over product quality. "In this way, vertical integration enables us to target specific customer profiles, generating a higher rate of return with each strain and product design. Pharmagreen has a strong focus on genetics which also puts us in a better position to develop new proprietary strains and supply tissue cultured starter plantlets to third-party growers."

Dr. Fawzia Afreen (Ph. D. in Botany), head of research and development of the research partner company, comments, “The ongoing successful development of the Initiation protocol and Multiplication protocols for our varieties of Cannabis strains and other high valued plant species, is another major benefit for Pharmagreen for future mass production of the disease-free, healthy, all genetically the same, tissue cultured starting material for mass scale production, at Pharmagreen’s tissue culture starter plantlet production facilities.”

For more information:

Publication date:

Receive the daily newsletter in your email for free | Click here

Other news in this sector:

Sign up for our daily Newsletter and stay up to date with all the latest news!

Subscribe I am already a subscriber